US · Healthcare

Benchmark Botanics Inc (BHHKF)

Drug Manufacturers - Specialty & Generic

Benchmark Botanics Inc (BHHKF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BHHKF

P/E ratio

18.00

Benchmark Botanics Inc (BHHKF) — FAQ

What is BHHKF's P/E ratio?

The price-to-earnings (P/E) ratio for Benchmark Botanics Inc (BHHKF) is 18.00 (data as of 2026-03-23).

Does Benchmark Botanics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Benchmark Botanics Inc (BHHKF). Check the MyAverix Finance app for the latest dividend data.

What sector is Benchmark Botanics Inc in?

Benchmark Botanics Inc (BHHKF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is BHHKF listed on?

BHHKF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)